|
Read more ›› |
By: GlobeNewswire - 05 Mar 2024
|
Related companies:
Agios Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Mar 2024
|
Related companies:
Axsome Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Mar 2024
|
Related companies:
ADMA Biologics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Mar 2024
|
Related companies:
First Wave BioPharma, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Mar 2024
|
Related companies:
Oxford Biomedica plc |
|
|
Read more ›› |
By: GlobeNewswire - 05 Mar 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 05 Mar 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 05 Mar 2024
|
Related companies:
AxoGen, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Mar 2024
|
Related companies:
Monopar Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Mar 2024
|
Related companies:
Cartesian Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Mar 2024
|
Related companies:
BioCryst Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Mar 2024
|
Related companies:
Cartesian Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Mar 2024
|
Related companies:
Tecan Group Ltd. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Mar 2024
|
Related companies:
Mereo BioPharma Group plc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Mar 2024
|
Related companies:
Dyne Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Mar 2024
|
Related companies:
Neuronetics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Mar 2024
|
Related companies:
SIGA Technologies, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Mar 2024
|
Related companies:
Ocular Therapeutix, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Mar 2024
|
Related companies:
Lava Therapeutics N.V. |
|
|
Read more ›› |
By: GlobeNewswire - 05 Mar 2024
|
Related companies:
Abeona Therapeutics, Inc. |
|